Latest CVD Stories

WOODBRIDGE, ON, May 7, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, presented positive, statistically significant, top-line results from its VASCAZEN(®)-REVEAL trial for the Company's lead product VASCAZEN(®), a unique >90% pure Omega-3 prescription medical food with a proprietary 6:1 EPA:DHA fatty acid formulation. The results...

Many people survive their cancers, but end up dying of cardiovascular disease (CVD). New research from Wake Forest Baptist Medical Center finds that CVD risk factors may be overlooked during survivorship care. Kathryn E. Weaver, Ph.D., assistant professor of social sciences and health policy at Wake Forest Baptist, and colleagues surveyed survivors of breast, prostate, colorectal and gynecologic cancers in search of answers. "Increasingly, we are concerned about cardiovascular health in...

WOODBRIDGE, ON, April 9, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that VASCAZEN(®) met its primary endpoint in the REVEAL trial. Additionally, VASCAZEN(®) achieved statistical significance in various secondary endpoints in patients presenting with elevated triglycerides (>200mg/dL < 500mg/dL). The...

Research from Boston University School of Medicine (BUSM) shows that improving vitamin D status by increasing its level in the blood could have a number of non-skeletal health benefits. The study, published online in PLOS ONE, reveals for the first time that improvement in the vitamin D status of healthy adults significantly impacts genes involved with a number of biologic pathways associated with cancer, cardiovascular disease (CVD), infectious diseases and autoimmune diseases. While...

Material Available to Commercial Partners for Enhanced Sensing Applications PHILADELPHIA, March 18, 2013 /PRNewswire/ -- AT PITTCON 2013, Element Six, the world leader in synthetic diamond supermaterials and member of the De Beers Group of Companies, today announced that it has engineered DIAFILM EA (Electroanalysis grade) in collaboration with The University of Warwick. The free-standing, solid boron doped microwave chemical vapor deposition (CVD) diamond electrode is expected to...

DURHAM, N.C., Dec. 20, 2012 /PRNewswire/ -- Analysis of the American Migraine Prevention and Prevalence (AMPP) study database indicate that a substantial proportion of persons with migraine also have cardiovascular events, cardiovascular disease (CVD), or CVD risk factors. These conclusions from the AMPP study are based upon an evaluation of 6,723 people with migraine, identified by screening a representative sample of over 160,000 Americans. The study showed that: 18% of...

WASHINGTON, Dec. 18, 2012 /PRNewswire-USNewswire/ -- The Department of Commerce ("Commerce") today issued its final results in the antidumping (AD) and countervailing duty (CVD) investigation of Chinese producers of utility scale wind towers and its final results in the antidumping investigation of Vietnamese producers of utility scale wind towers. In its final results, Commerce found that Chinese producers dumped towers in the United States at rates of between 44.99% to 70.63% and...

Georgia Institute of Technology Research News The electronic properties of graphene films are directly affected by the characteristics of the substrates on which they are grown or to which they are transferred. Researchers are taking advantage of this to create graphene p-n junctions by transferring films of the promising electronic material to substrates that have been patterned by compounds that are either strong electron donors or electron acceptors. A low temperature, controllable...

Relatives of young people who have died suddenly from a heart-related problem are at greatly increased risk of developing cardiovascular disease according to a study published online today (Wednesday) in the European Heart Journal. The authors of the study say these findings have two major implications; firstly, they strongly support the fact that autopsies should always be performed in cases of young sudden unexplained death; and secondly, since the involved diseases are all treatable if...

ROSSENS, Switzerland, Nov. 8, 2012 /PRNewswire/ -- Maxwell Technologies, Inc. (Nasdaq: MXWL), a leading producer of energy storage and power delivery products, announced today that its Swiss subsidiary has introduced a line of high-voltage capacitors and capacitive voltage dividers (CVD) that operate normally at temperatures down to -60 degrees C for electric utility grid installations in regions that experience extremely low temperatures. (Logo:...